🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHas anyone dealt with orforglipron phase 2 weight loss data? Page 5

Has anyone dealt with orforglipron phase 2 weight loss data?

BariatricNurseD Mon, Apr 7, 2025 at 12:45 AM 23 replies 1,601 viewsPage 5 of 5
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Apr 7, 2025 at 7:50 AM#21

Dr.NateNeph — that is really helpful context on Has anyone dealt with. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

38 22pete_nash, hank_denver, carlos_SATX and 35 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Apr 7, 2025 at 8:07 AM#22

To answer carlos_SATX's question specifically:

From a clinical standpoint, Has anyone dealt with is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

1 15Dr.NateNeph
Reply Quote Save Share Report
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
Apr 7, 2025 at 8:24 AM#23

Thank you SleepDoc_PDX! This is incredibly helpful. Taking this to my next appointment. 🙏

13 24mike_mealprep, NicoleRaleigh, james_edin and 10 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Apr 7, 2025 at 8:41 AM#24

Relevant to Has anyone dealt with — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 207 → 107 mg/dL, hsCRP 6.0 → 1.3 mg/L. All on tirzepatide for 11 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

42 4VendorMark, COA_Karl, MikeFit_NJ and 39 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Apr 7, 2025 at 8:58 AM#25

Slightly tangential to Has anyone dealt with but SleepDoc_PDX reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

47 10LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 44 others
Reply Quote Save Share Report
1345

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register